Open AccessEffect of Postmenopausal Hormone Therapy on Lipoprotein(a) Concentration
Author(s) -
Mark A. Espeland,
Santica M. Marcovina,
Valery T. Miller,
Peter D. Wood,
Carol H. Wasilauskas,
Roger Sherwin,
Helmut G. Schrott,
Trudy L. Bush
Publication year - 1998
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.97.10.979
Subject(s) - medicine , medroxyprogesterone acetate , hormone therapy , placebo , progestin , estrogen , endocrinology , hormone replacement therapy (female to male) , menopause , lipoprotein , lipoprotein(a) , hormone , cholesterol , breast cancer , testosterone (patch) , cancer , alternative medicine , pathology
Postmenopausal hormone therapy has been reported to decrease levels of lipoprotein (Lp)(a) in cross-sectional studies and small or short-term longitudinal studies. We report findings from a large, prospective, placebo-controlled clinical trial that allows a broad characterization of these effects for four regimens of hormone therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom